{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/XSTO/SE0006371126",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Cantargia AB (Nasdaq Stockholm: SE0006371126) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Cantargia AB, listed on Nasdaq Stockholm under ticker SE0006371126, with ISIN SE0006371126 and LEI 549300GKWRT7RXI4VS85. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 34 filings across 31 filing days in the twelve months to 2026-11-06. The median gap between filing days is 9.0 days, and the latest filing is dated 2026-11-05, 1 day before the record date. The latest filing type is Investor News. The Nasdaq Stockholm peer medians are 9.5 days of cadence, 30.0 filings and 7.0 days of latency across 398 issuers. Sector peer figures are not on the record for this market.\n\n## Auditor\n\nThe auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.\n\n## Events and halts\n\nThe record carries no listing, delisting, name change, domicile change or segment move lines, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable for this issuer. The orderability section of the chapter carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 4 research houses: DNB Carnegie, REDEYE, Van Lanschot Kempen and H.C. Wainwright.\n\n## Open research\n\nThe record holds 8 openly published research notes. Redeye has published 4, Edison Investment Research Limited has published 3 and Nordea Markets has published 1. The most recent is dated 2025-02-24 and the earliest 2021-03-10.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market has no earliest sealed date, and the live record start is not on the record.\n\n## Sources\n\n15 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/XSTO/SE0006371126 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://cantargia.com/en/investors/analyst-coverage (coverage)\n- https://cantargia.com/assets/uploads/Redeye-Research-Update-250224.pdf (open research)\n- https://cantargia.com/assets/uploads/Redeye-Research-Note-231031.pdf (open research)\n- https://cantargia.com/assets/uploads/Redeye-Analysis-Cantargia-Q4-2022-230224.pdf (open research)\n- https://cantargia.com/assets/uploads/Redeye-Research-Note-Cantargia-230116.pdf (open research)\n- https://cantargia.com/assets/uploads/Nordea-Cantargia_Commissioned_Research_310822.pdf (open research)\n- https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-220831.pdf (open research)\n- https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-220524.pdf (open research)\n- https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-210310.pdf (open research)\n- https://mcp.se-cm-kg.ai/record/XSTO/SE0006371126 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/XSTO/SE0006371126",
  "coverage": {
   "count": 4,
   "houses": [
    {
     "analyst": "Arvid Necander",
     "house": "DNB Carnegie",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/en/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Richard Ramanius",
     "house": "REDEYE",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/en/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Sebastiaan van der Schoot",
     "house": "Van Lanschot Kempen",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/en/investors/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Sara Nik, Ph.D. and Joe Pantginis, Ph.D",
     "house": "H.C. Wainwright",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/en/investors/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://cantargia.com/en/investors/analyst-coverage",
     "result": "read: 4 of 8 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 398,
     "median_cadence_gap_days": 9.5,
     "median_filings": 30,
     "median_latency_days": 7,
     "name": "Nasdaq Stockholm"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual Financial Report": 1,
    "Changes board/management/auditors": 1,
    "Decisions of general meeting": 1,
    "Financial Statement Release": 1,
    "Half Year financial report": 1,
    "Inside information": 3,
    "Interim report (Q1 and Q3)": 2,
    "Investor News": 18,
    "Notice to general meeting": 1,
    "Other information disclosed according to the rules of the Exchange": 3,
    "Prospectus/Announcement of Prospectus": 1,
    "Total number of voting rights and capital": 1
   },
   "cadence_median_gap_days": 9,
   "filing_days": 31,
   "filings": 34,
   "latency_days": 1,
   "latest": [
    {
     "category": "Investor News",
     "date": "2026-11-05",
     "source": "https://view.news.eu.nasdaq.com/view?id=b16f43491fa1e8525174fc5337d3c8feb&lang=en&src=listed",
     "title": "Cantargia to host Q3 2026 Interim Results Conference Call",
     "type": "Investor News"
    },
    {
     "category": "Inside information",
     "date": "2026-11-04",
     "source": "https://view.news.eu.nasdaq.com/view?id=b94165d7663321e0525dbd819f1781f38&lang=en&src=listed",
     "title": "Cantargia Presents Promising Early Results with Nadunolimab in MDS and AML Ahead of ASH 2026",
     "type": "Inside information"
    },
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-10-29",
     "source": "https://view.news.eu.nasdaq.com/view?id=bbc38e522a34d7fafcc292c7062699b98&lang=en&src=listed",
     "title": "Cantargia presents Nomination Committee ahead of 2027 AGM",
     "type": "Other information disclosed according to the rules of the Exchange"
    },
    {
     "category": "Investor News",
     "date": "2026-10-27",
     "source": "https://view.news.eu.nasdaq.com/view?id=bf535d9ca571d80b75adbb620a6463d97&lang=en&src=listed",
     "title": "Cantargia to Present at the Stifel 2026 Healthcare Conference",
     "type": "Investor News"
    },
    {
     "category": "Changes board/management/auditors",
     "date": "2026-10-26",
     "source": "https://view.news.eu.nasdaq.com/view?id=b8c50ba2eb820e1827c8c69dee8d8a84b&lang=en&src=listed",
     "title": "Cantargia appoints Dr. Monic Stuart as Chief Medical Officer",
     "type": "Changes board/management/auditors"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0006371126",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Nasdaq Stockholm"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0006371126"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0006371126)",
    "state": "sourced",
    "value": "549300GKWRT7RXI4VS85"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Cantargia AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0006371126"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:7e92e7deb8474ce04f5dcd34ae22a78f837c48cf75650c031ac58a52c1b095e2",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2025-02-24",
     "kind": "independent",
     "publisher": "Redeye",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Redeye-Research-Update-250224.pdf",
     "state": "sourced",
     "title": "Cantargia Q4 2024: Focus on Business Development"
    },
    {
     "date": "2023-10-31",
     "kind": "independent",
     "publisher": "Redeye",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Redeye-Research-Note-231031.pdf",
     "state": "sourced",
     "title": "Cantargia: Cash Runway Extended into 2025"
    },
    {
     "date": "2023-02-24",
     "kind": "independent",
     "publisher": "Redeye",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Redeye-Analysis-Cantargia-Q4-2022-230224.pdf",
     "state": "sourced",
     "title": "Progress in Triple-Negative Breast Cancer"
    },
    {
     "date": "2023-01-16",
     "kind": "independent",
     "publisher": "Redeye",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Redeye-Research-Note-Cantargia-230116.pdf",
     "state": "sourced",
     "title": "Cantargia: Comments on CAN10’s toxicity study and the share price rally"
    },
    {
     "date": "2022-08-31",
     "kind": "issuer-sponsored",
     "publisher": "Nordea Markets",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Nordea-Cantargia_Commissioned_Research_310822.pdf",
     "state": "sourced",
     "title": "Commissioned Equity Research"
    },
    {
     "date": "2022-08-31",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research Limited",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-220831.pdf",
     "state": "sourced",
     "title": "Cantargia"
    },
    {
     "date": "2022-05-24",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research Limited",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-220524.pdf",
     "state": "sourced",
     "title": "Cantargia"
    },
    {
     "date": "2021-03-10",
     "kind": "issuer-sponsored",
     "publisher": "Edison Investment Research Limited",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-210310.pdf",
     "state": "sourced",
     "title": "Cantargia"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/XSTO/SE0006371126",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:7e92e7deb8474ce04f5dcd34ae22a78f837c48cf75650c031ac58a52c1b095e2",
 "path": "/se/XSTO/SE0006371126",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Cantargia AB, listed on Nasdaq Stockholm under ticker SE0006371126, with ISIN SE0006371126 and LEI 549300GKWRT7RXI4VS85. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 34 filings across 31 filing days in the twelve months to 2026-11-06. The median gap between filing days is 9.0 days, and the latest filing is dated 2026-11-05, 1 day before the record date. The latest filing type is Investor News. The Nasdaq Stockholm peer medians are 9.5 days of cadence, 30.0 filings and 7.0 days of latency across 398 issuers. Sector peer figures are not on the record for this market.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record carries no listing, delisting, name change, domicile change or segment move lines, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable for this issuer. The orderability section of the chapter carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 4 research houses: DNB Carnegie, REDEYE, Van Lanschot Kempen and H.C. Wainwright.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 8 openly published research notes. Redeye has published 4, Edison Investment Research Limited has published 3 and Nordea Markets has published 1. The most recent is dated 2025-02-24 and the earliest 2021-03-10.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market has no earliest sealed date, and the live record start is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "15 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0006371126"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://cantargia.com/en/investors/analyst-coverage"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Redeye-Research-Update-250224.pdf"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Redeye-Research-Note-231031.pdf"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Redeye-Analysis-Cantargia-Q4-2022-230224.pdf"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Redeye-Research-Note-Cantargia-230116.pdf"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Nordea-Cantargia_Commissioned_Research_310822.pdf"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-220831.pdf"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-220524.pdf"
  },
  {
   "for": "open research",
   "source": "https://cantargia.com/assets/uploads/Edison-Analys-Cantargia-210310.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/XSTO/SE0006371126"
  }
 ],
 "title": "Cantargia AB (SE0006371126) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}